Vaccines having an antigen and interleukin-21 as an adjuvant
US11007265B2 · kind B2 · utility
0Cited by
0References
16Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Nov 6, 2018 |
| Grant date | May 18, 2021 |
| Priority date | — |
| Expiry date | Nov 6, 2038 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed herein is a vaccine comprising an antigen and IL-21. Also disclosed herein are methods for increasing an immune response in a subject. The methods may comprise administering the vaccine to the subject in need thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.